Fritz, Ildikó, et al. “Desloratadine and Loratadine Stand Out Among Common H1-Antihistamines for Association With Improved Breast Cancer Survival”. Acta Oncologica, vol. 59, no. 9, Sept. 2020, pp. 1103-9, doi:10.1080/0284186X.2020.1769185.